P685: LATE PHASE BCR-ABL DECLINE PREDICTS THE DURATION OF TKI (IMATINIB) FOR SUCCESSFUL TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA.

• Chethan R,
• Prabath Singh Malik,
• Ranjit Kumar Sahoo,
• Raja Pramannik,
• Vikas Garg,
• Sudhir Kirar,
• Kanupriya Bhatia,
• Anura Kantak,
• Atul Sharma,
• Lalit Kumar

Affiliations

Chethan R

1 All India Institute Of Medical Sciences, New Delhi, India

Prabath Singh Malik

1 All India Institute Of Medical Sciences, New Delhi, India

Ranjit Kumar Sahoo

1 All India Institute Of Medical Sciences, New Delhi, India

Raja Pramannik

1 All India Institute Of Medical Sciences, New Delhi, India

Vikas Garg

1 All India Institute Of Medical Sciences, New Delhi, India

Sudhir Kirar

1 All India Institute Of Medical Sciences, New Delhi, India

Kanupriya Bhatia

1 All India Institute Of Medical Sciences, New Delhi, India

Anura Kantak

1 All India Institute Of Medical Sciences, New Delhi, India

Atul Sharma

1 All India Institute Of Medical Sciences, New Delhi, India

Lalit Kumar

1 All India Institute Of Medical Sciences, New Delhi, India